CIRM-funded clinical trial aimed at blocking HIV/AIDS in people gets the go ahead
An innovative therapy using a patient’s own stem cells, modified to resist infection with the AIDS virus, has been given approval by the Food and Drug Administration (FDA) to begin a clinical …